These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30827473)

  • 41. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between changes in peak expiratory flow and asthma exacerbations in asthmatic children.
    Chen X; Han P; Kong Y; Shen K
    BMC Pediatr; 2024 Apr; 24(1):284. PubMed ID: 38678177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of CAT Score With Peak Expiratory Flow in Acute Exacerbation of COPD Patients.
    Kavalci C; Yilmaz MS; Kayipmaz AE; Isık B; Celikel E; Kavalci G; Yilmaz F; Ozlem M; Sonmez BM; Celebi S
    J Natl Med Assoc; 2016; 108(3):164-168. PubMed ID: 27692357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is insufficient pulmonary air support the cause of dysphonia in chronic obstructive pulmonary disease?
    Hassan MM; Hussein MT; Emam AM; Rashad UM; Rezk I; Awad AH
    Auris Nasus Larynx; 2018 Aug; 45(4):807-814. PubMed ID: 29325856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
    Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.
    Calverley P; Pauwels Dagger R; Löfdahl CG; Svensson K; Higenbottam T; Carlsson LG; Ståhl E
    Eur Respir J; 2005 Sep; 26(3):406-13. PubMed ID: 16135720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.
    Anzueto A; Niewoehner DE; Leimer I; Rühmkorf F; Celli BR; Decramer M; Tashkin DP
    Respir Med; 2013 Dec; 107(12):1912-22. PubMed ID: 23969305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD.
    Wei X; Ma Z; Yu N; Ren J; Jin C; Mi J; Shi M; Tian L; Gao Y; Guo Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():121-129. PubMed ID: 29343951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 59. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hospitalizations due to exacerbations of COPD: A big data perspective.
    Serra-Picamal X; Roman R; Escarrabill J; García-Altés A; Argimón JM; Soler N; Faner R; Carbonell EM; Trilla A; Agusti A
    Respir Med; 2018 Dec; 145():219-225. PubMed ID: 29398283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.